Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Late Breaking Results of the First International Multicenter Trial of Islet Transplantation in Type 1 Diabetes with the Edmonton Protocol

Go back to Resources

Late Breaking Results of the First International Multicenter Trial of Islet Transplantation in Type 1 Diabetes with the Edmonton Protocol

Authors:

Location:

Go back to Resources

Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease

Go back to Resources

Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease

Authors:

Location:

Go back to Resources

Initial Results of the Protein Kinase C b Inhibitor Diabetic Macular Edema Study (PKC-DMES)

Go back to Resources

Initial Results of the Protein Kinase C b Inhibitor Diabetic Macular Edema Study (PKC-DMES)

Authors:

Location:

Go back to Resources

Impact of Antioxidants, Zinc, and Copper on Cognition in the Elderly: A Randomized, Controlled Trial

Go back to Resources

Impact of Antioxidants, Zinc, and Copper on Cognition in the Elderly: A Randomized, Controlled Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Impact of antioxidants, zinc, and copper on cognition in the elderly. A randomized, controlled trial. AREDS Report No. 12

Go back to Resources

Impact of antioxidants, zinc, and copper on cognition in the elderly. A randomized, controlled trial. AREDS Report No. 12

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Illustration of the AMD severity scale from the Age-Related Eye Disease Study

Go back to Resources

Illustration of the AMD severity scale from the Age-Related Eye Disease Study

Authors:

Location:

Go back to Resources

A Randomized, Controlled Trial of Antioxidants and Zinc and the Impact on Cognition in the Elderly: The AREDS Ancillary Trial

Go back to Resources

A Randomized, Controlled Trial of Antioxidants and Zinc and the Impact on Cognition in the Elderly: The AREDS Ancillary Trial

Authors:

Location:

Go back to Resources

A Prospective, randomized, double blind, multicenter trial of early (7 day) corticosteroid cessation vs long term low dose corticosteroid therapy under tacrolimus and mycopheonlate mofetil therapy with antibody induction

Go back to Resources

A Prospective, randomized, double blind, multicenter trial of early (7 day) corticosteroid cessation vs long term low dose corticosteroid therapy under tacrolimus and mycopheonlate mofetil therapy with antibody induction

Authors:

Go back to Resources

A prospective, randomized, trial of the effect of multi-center trial of antibody induction in simultaneous pancreas and kidney transplantation: three year results

Go back to Resources

A prospective, randomized, trial of the effect of multi-center trial of antibody induction in simultaneous pancreas and kidney transplantation: three year results

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

(Collaborative Islet Transplant Registry [CITR])

Go back to Resources

(Collaborative Islet Transplant Registry [CITR])

Authors:

Secondary:

Volume:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 140
  • Page 141
  • Page 142
  • Page 143
  • Current page 144
  • Page 145
  • Page 146
  • Page 147
  • Page 148
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions